C. Correll

发表

Severe mental illness: cardiovascular risk assessment and management

C. Polcwiartek, Svend Eggert Jensen, M. Solmi, 2024, European heart journal.

Regional differences in mortality risk and in attenuating or aggravating factors in schizophrenia: A systematic review and meta-analysis

J. Tiihonen, D. Vancampfort, M. Nordentoft, 2024, European Neuropsychopharmacology.

Placebo effects in mental health disorders: protocol for an umbrella review

Marco Solmi, N. T. Huneke, David S Baldwin, 2023, BMJ open.

An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders

G. Ostuzzi, P. Fusar-Poli, L. Eudave, 2023, Molecular psychiatry.

Frequency and Correlates of Distant Visual Impairment in Patients with Schizophrenia, Bipolar Disorder, and Major Depressive Disorder.

C. Correll, G. Ungvari, Y. Xiang, 2015, East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan.

Vitamin K antagonists' use and fracture risk: results from a systematic review and meta‐analysis

G. Sergi, N. Veronese, E. Manzato, 2015, Journal of thrombosis and haemostasis : JTH.

Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderators

J. Tiihonen, D. Vancampfort, M. Nordentoft, 2024, European Neuropsychopharmacology.

Vitamin K antagonists' use and fracture risk: results from a systematic review and meta‐analysis: reply

C. Correll, N. Veronese, M. Solmi, 2016, Journal of thrombosis and haemostasis : JTH.

Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis

G. Fond, F. Iasevoli, A. de Bartolomeis, 2024, Research square.

Patient characteristics, validity of clinical diagnoses and Outcomes Associated with Suicidality in Inpatients with Symptoms of Depression (OASIS-D): design, procedures and outcomes

M. Adli, A. Meyer-Lindenberg, V. Nöhles, 2023, BMC Psychiatry.

A state-of-the-art overview of candidate diagnostic biomarkers for Attention-deficit/hyperactivity disorder (ADHD)

L. Margari, Emilia Matera, M. Petruzzelli, 2024, Expert review of molecular diagnostics.

The role of meta-analyses and umbrella reviews in assessing the harms of psychotropic medications: beyond qualitative synthesis

Marco Solmi, Andre F. Carvalho, J. P. Ioannidis, 2018, Epidemiology and Psychiatric Sciences.

Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives

T. Kishimoto, C. Correll, J. Kane, 2011, Dialogues in clinical neuroscience.

Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia.

A. Tanskanen, J. Tiihonen, J. Luykx, 2024, JAMA psychiatry.

Serotonin transporter gene polymorphism in eating disorders: Data from a new biobank and META-analysis of previous studies

C. Correll, N. Veronese, M. Solmi, 2016, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Real‐world effectiveness of antidepressants, antipsychotics and their combinations in the maintenance treatment of psychotic depression. Evidence from within‐subject analyses of two nationwide cohorts

A. Tanskanen, J. Tiihonen, E. Mittendorfer-Rutz, 2024, World psychiatry : official journal of the World Psychiatric Association.

Outcomes in people with eating disorders: a transdiagnostic and disorder‐specific systematic review, meta‐analysis and multivariable meta‐regression analysis

A. Monteleone, P. Meneguzzo, E. Collantoni, 2024, World psychiatry : official journal of the World Psychiatric Association.